fibrinogen has been researched along with ANCA-Associated Vasculitides in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bao, X; Ji, C; Sun, J; Yuan, C; Zhang, N; Zhou, Y | 1 |
Ahn, SS; Lee, LE; Lee, SW; Park, YB; Pyo, JY; Song, JJ | 1 |
Ford, SL; Holdsworth, SR; Kitching, AR; Longano, A; O'Sullivan, KM | 1 |
Hilhorst, M; ten Cate, H; Tervaert, JW; van Oerle, R; Wilde, B; Winckers, K | 1 |
4 other study(ies) available for fibrinogen and ANCA-Associated Vasculitides
Article | Year |
---|---|
Clinical significance and influencing factors of fibrinogen in ANCA-associated vasculitis: A single-center retrospective study from Southwest China.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Bacterial Infections; China; Female; Fibrinogen; Humans; Male; Middle Aged; Retrospective Studies | 2020 |
Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Aged; Albumins; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Fibrinogen; Follow-Up Studies; Humans; Linear Models; Male; Survival Rate | 2021 |
Intrarenal Toll-like receptor 4 and Toll-like receptor 2 expression correlates with injury in antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Female; Fibrinogen; Glomerular Filtration Rate; Glomerulonephritis; HMGB1 Protein; Humans; Kidney Glomerulus; Male; Middle Aged; Peroxidase; Receptor, PAR-1; Severity of Illness Index; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptor 9 | 2018 |
Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Protein C; Protein S; Remission Induction; Risk Factors; Thrombin; Thrombophilia; Venous Thromboembolism | 2013 |